The insider sales are too small to signal any material concern.
PCRX drugs
PCRX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 15 $22.74entry
- T+1 · 5mo ago +0.35%α +0.95% · $22.82
- T+5 · 5mo ago −0.13%α +1.25% · $22.71
- T+20 · 4mo ago +12.31%α +13.06% · $25.54
- T+60 · 2mo ago +13.81%α +12.81% · $25.88
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Pacira BioSciences saw two insider sales totaling $372K over a week, including the Chief Administrative Officer and SVP of Finance. The total value is 0.04% of the $905M market cap, which is trivial. The cluster is dominated by non-cash director grants ($0 value) that carry no economic signal, making the selling activity routine and non-informative.
Key Financial Metrics
Key Facts
- Two insiders sold shares: CAO Kristen Williams ($228K) and SVP Finance Lauren Riker ($144K), total $372K.
- Total selling value is 0.04% of $905M market cap, trivial and routine.
- 14 director grants (non-cash, $0 value) occurred on 2026-06-10, representing standard equity compensation, not a trading signal.
Financial Impact
Insider sales of $372K represent 0.04% of market cap, immaterial.
Risk Factors
- No material insider buying to offset the selling pattern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCRX-1781312904049 |
Track record
29 reports on PCRX
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +42.26% at T+60 after the Aug 6, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $36.46 Now $36.48 −0.05% settles Dec 14
- Nov 12, 20264d ago SC TO-T/A Mixed 7/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
- Nov 12, 20264d ago SC 14D-9/A Neutral 3/10 Entry $36.46 Now $36.48 +0.05% settles Dec 14
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $36.43 Now $36.48 +0.14% settles Dec 7
- Nov 3, 202613d ago SC 14D-9/A Neutral 3/10 Entry $36.40 Now $36.48 +0.22% settles Dec 3
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
- Oct 30, 202617d ago SC 14D-9 Bullish 7/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
- Oct 30, 202617d ago SC TO-T Mixed 7/10 Entry $36.39 Now $36.48 +0.25% settles Nov 30
- Oct 13, 20264w ago SC 13D/A Bearish 7/10 Entry $36.40 to $36.46 Now $36.48 −0.22% ▼ −0.16% −1.44% vs SPY
- Oct 8, 20265w ago SC TO-C Bullish 7/10 Entry $36.31 to $36.43 Now $36.48 +0.47% ▲ +0.33% +5.89% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers